Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-008191
Filing Date
2025-01-31
Accepted
2025-01-31 17:13:52
Documents
5
Effectiveness Date
2025-01-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm254943d2_s8.htm S-8 67086
2 EXHIBIT 5.1 tm254943d2_ex5-1.htm EX-5.1 9682
3 EXHIBIT 23.1 tm254943d2_ex23-1.htm EX-23.1 2636
4 EX-FILING FEES tm254943d2_ex-filingfees.htm EX-FILING FEES 16294
5 GRAPHIC tm254988d1_ex5-1img01.jpg GRAPHIC 3639
  Complete submission text file 0001104659-25-008191.txt   102098
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-284649 | Film No.: 25579412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)